European Trial of Pirfenidone in BOS, A European Multi-center Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Disorder Related to Lung TransplantationCLAD, Bronchiolitis Obliterans
Interventions
DRUG

Pirfenidone

Receive tablets with pirfenidone

DRUG

Placebo

Recieve tablets with placebo

Trial Locations (9)

300

University Hospital Gasthuisberg, Katholike Universiteit Leuven, Leuven

2100

Rigshospitalet, Copenhagen University Hospital, Copenhagen

9700

Groningen University Medical Center, Lung Transplant Team, Groningen

30625

Medizinische Hochschule Hannover, Klinik für Pneumonologie, Hanover

41345

Sahlgrenska University Hospital, Department of respiratory diseases, Gothenburg

45239

University Hospital Essen, Department of Pneumonology, Essen

81377

Klinikum Grosshadern, Division of Pulmonary Diseases, Munich

0424

Rikshospitalet, National University Hospital, Oslo

NE7 7DN

Freeman Hospital, Newcastle

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02262299 - European Trial of Pirfenidone in BOS, A European Multi-center Study | Biotech Hunter | Biotech Hunter